You're viewing our new website - find out more

Publication - Consultation Paper

Clinical Trial Access quality performance indicator: consultation

Published: 3 Jul 2017
Part of:
Health and social care

Consultation on the effectiveness of the Clinical Trial Access quality performance indicator (QPI) as part of the National Cancer QPIs.

20 page PDF


20 page PDF


Clinical Trial Access quality performance indicator: consultation
8. Reporting

20 page PDF


8. Reporting

The Clinical Trial Access QPI will be reported alongside tumour specific QPIs for the most recent calendar year. The patient cohort used to measure the Clinical Trial Access QPI is different to that of the tumour specific QPIs due to the methodology utilised and it is therefore not necessary to use an identical timeframe for reporting. In order to avoid multiple data requests to SCRN for different tumour groups it is considered most appropriate to align the tumour sites to one calendar year for reporting purposes.

Additional information will be reported alongside the QPI in order to provide further context for each tumour site. This will include the following:

  • Details of all clinical trials open to recruitment in each cancer centre during the audit period.
  • Percentage of patients enrolled in clinical trials.


Added section 7: Methodology (previously text within the QPI)

Updated section 8: Reporting


Email: Chris Booth,

Phone: 0300 244 4000 – Central Enquiry Unit

The Scottish Government
St Andrew's House
Regent Road